-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, GjU7jv8oTtIQtQtKGX4a/D8pmV0Aekk3aUbdxFbap1z8NkkQB2Mqin1p8ueUMayJ /IZmg0m9yyA98v34IB5r3w== 0001162044-05-000050.txt : 20050301 0001162044-05-000050.hdr.sgml : 20050301 20050301150526 ACCESSION NUMBER: 0001162044-05-000050 CONFORMED SUBMISSION TYPE: N-Q PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20041231 FILED AS OF DATE: 20050301 DATE AS OF CHANGE: 20050301 EFFECTIVENESS DATE: 20050301 FILER: COMPANY DATA: COMPANY CONFORMED NAME: JHAVERI TRUST CENTRAL INDEX KEY: 0000937818 IRS NUMBER: 341791544 STATE OF INCORPORATION: OH FISCAL YEAR END: 0331 FILING VALUES: FORM TYPE: N-Q SEC ACT: 1940 Act SEC FILE NUMBER: 811-08974 FILM NUMBER: 05649794 BUSINESS ADDRESS: STREET 1: PO BOX 16188 CITY: CLEVELAND STATE: OH ZIP: 44116 BUSINESS PHONE: 5163859580 MAIL ADDRESS: STREET 1: 18820 HIGH PARKWAY CITY: CLEVELAND STATE: OH ZIP: 44116 N-Q 1 jhaverinq022005.htm Jhaveri Value Fund  

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, DC 20549



FORM N-Q


QUARTERLY SCHEDULE OF PORTFOLIO HOLDINGS OF REGISTERED

 MANAGEMENT INVESTMENT COMPANY


Investment Company Act file number 811-8974


The Jhaveri Trust

(Exact name of registrant as specified in charter)


18820 High Parkway, Cleveland, Ohio 44116

(Address of principal executive offices)

(Zip code)


Ramesh C. Jhaveri, 18820 High Parkway, Cleveland, Ohio 44116

(Name and address of agent for service)


With copy to:

Donald S. Mendelsohn, Thompson Hine LLP.

312 Walnut St., 14th Floor, Cincinnati, Ohio 45202



Registrant's telephone number, including area code: (440) 356-1565


Date of fiscal year end: March 31


Date of reporting period: December 31, 2004


Form N-Q is to be used by management investment companies, other than small business investment companies registered on Form N-5 (ss.ss. 239.24 and 274.5 of this chapter), to file reports with the Commission, not later than 60 days after the close of the first and third fiscal quarters, pursuant to rule 30b1-5 under the Investment Company Act of 1940 (17 CFR 270.30b1-5).  The Commission may use the information provided on Form N-Q in its regulatory, disclosure review, inspection, and policymaking roles.

A registrant is required to disclose the information specified by Form N-Q, and the Commission will make this information public. A registrant is not required to respond to the collection of information contained in Form N-Q unless the Form displays a currently valid Office of Management and Budget ("OMB") control number.  Please direct comments concerning the accuracy of the information collection burden estimate and any suggestions for reducing the burden to the Secretary, Securities and Exchange Commission, and 450 Fifth Street, NW, Washington, DC 20549-0609.  The OMB has reviewed this collection of information under the clearance requirements of 44 U.S.C. ss. 3507.



ITEM 1. SCHEDULE OF INVESTMENTS.



Jhaveri Value Fund  

 

   
 

Schedule of Investments

 

December 31,2004 (Unaudited)

 Shares/Principal Amt- % of Assets

       Market Value

   

 COMMON STOCKS

 
   

 Agricultural Prod-Livestock & Animal Specialties - 0.12%

 

   1,000

Cal Maine Foods, Inc.

 $      12,090

 

 

 

 American Depositary Receipts - 0.42%

 

      500

Toyota Motor Corporation

40,935

   

 Beverages - 1.33%

 

   2,500

Pepsico, Inc.

130,500

 

 

 

 Bottled & Canned Soft Drinks - 1.48%

 

   3,500

Coca Cola Company

       145,705

   

 Communications Equipment - 0.11%

 

      500

UT Starcom, Inc. *

         11,075

 

 

 

 Computer & Office Equipment - 1.60%

 

   7,500

Hewlett-Packard Company

       157,275

   

 Computer Communications Equipment - 1.77%

 

   9,000

Cisco Systems, Inc. *

       173,880

 

 

 

 Crude Petroleum & Natural Gas - 0.33%

 

      500

Anadarko Petroleum Corporation

         32,405

   

 Dolls & Stuffed Toys - 0.30%

 

   1,500

Mattel, Inc.

         29,235

 

 

 

 Electromedical & Electrotherapy - 0.76%

 

   1,500

Medtronic, Inc.

         74,505

   

 Electric & Other Services Combined - 0.22%

 

      500

Consolidated Edison Company of New York, Inc.

         21,875

 

 

 

 Fire, Marine & Casualty Insurance - 0.33%

 

      500

American International Group, Inc.

         32,835

   

 Functions Related To Depository Banking, NEC - 0.01%

 

        30

A B N Amro Holding N V

  798

 

 

 

 Games, Toys & Children's Vehicles (No Dolls & Bicycles) - 1.38%

  10,000

Leapfrog Enterprises, Inc. *

       136,000

   

 Grain Mill Products - 0.25%

 

      500

General Mills, Inc.

         24,855

 

 

 

 Household Appliances - 1.29%

 

   6,000

Maytag Corporation

       126,600

   

 Household Audio & Video Equipment - 0.20%

 

      500

Sony Corporation

         19,480

 

 

 

 Ice Cream & Frozen Desserts - 0.17%

 

      500

Dean Foods Company*

         16,475

   

 Malt Beverages - 0.52%

 

   1,000

Anheuser Busch Companies, Inc.

         50,730

 

 

 

 Miscellaneous Manufacturing Industries - 0.52%

 

   1,500

International Game Technology

         51,570

   

 Motor Vehicles & Passenger Car Bodies - 0.82%

 

   2,000

General Motors Corporation

         80,120

 

 

 

 National Commercial Banks - 0.74%

 

   1,500

Citigroup, Inc.

         72,270

   

 Natural Gas Distribution - 0.38%

 

   1,000

Nicor, Inc.

         36,940

 

 

 

 Newspapers: Publishing or Publishing & Printing - 1.04%

 

      500

Gannett, Inc.

         40,850

   1,000

News Corporation

         19,200

   1,000

Tribune Company

         42,140

  

       102,190

 

 

 

 Oil & Gas Field Services, NEC - 0.47%

 

   1,000

B.J. Services Company

         46,540

   

 Orthopedic, Prosthetic & Surgical Appliances & Supplies - 0.41%

      500

Zimmer Holdings, Inc.*

         40,060

 

 

 

   

 Perfumes, Cosmetics & Other Toilet Preparations - 1.30%

 

   2,500

Colgate-Palmolive Company

       127,900

 

 

 

 Petroleum Refining - 0.46%

 

      500

Chevrontexaco Corporation

         26,255

      500

Marathon Oil Corporation

         18,805

 

 

         45,060

   

 Pharmaceutical Preparations - 16.82%

 

   6,500

Astrazeneca PLC

       236,535

   2,000

Bristol Myers Squibb Company

         51,240

   4,000

Chiron Corporation *

       133,320

   5,500

Forest Laboratories, Inc. Class A *

       246,730

   4,000

Lilly, Eli & Company

       227,000

   3,500

Merck & Company, Inc.

       112,490

   6,000

Mylan Laboratories, Inc.

       106,080

  18,500

Pfizer, Inc.

       497,465

   2,000

Schering-Plough Corporation

         41,760

 

 

     1,652,620

   

 Plastics Products - 0.12%

 

      500

Newell Rubbermaid, Inc.

         12,095

 

 

 

 Radio Broadcasting Stations - 0.34%

 

   1,000

Clear Channel Communications

         33,490

   

 Radio & Tv Broadcasting & Communications Equipment - 0.18%

   1,000

Motorola, Inc.

         17,200

 

 

 

 Retail-Grocery Stores - 0.30%

 

   1,500

Safeway, Inc.*

         29,610

   

 Retail-Miscellaneous Shopping - 0.18%

 

      500

Dick's Sporting Goods, Inc.*

         17,575

 

 

 

 Retail-Drug Stores and Proprietary Stores - 0.21%

 

      500

Medco Health Solutions, Inc.*

         20,800

   

 Retail-Jewelry Stores - 0.16%

 

      500

Tiffany & Company

         15,985

 

 

 

   

 Retail-Variety Stores - 0.54%

 

   1,000

Wal-Mart Stores, Inc.

         52,820

 

 

 

 Retail-Women's Clothing Stores - 0.67%

 

   2,000

Ann Taylor Stores Corporation*

         43,060

   1,000

Limited, Inc.

         23,020

 

 

         66,080

   

 Security Brokers, Dealers & Flotation Companies - 0.24%

 

   2,000

Schwab (Charles) Corporation

         23,920

 

 

 

 Semiconductors & Related Devices - 6.86%

 

   1,000

Altera Corporation 8

         20,700

   7,000

Applied Materials, Inc. *

       119,700

  16,200

Intel Corporation

       378,918

   1,000

STMicroelectronics NV

         19,320

   5,500

Texas Instruments, Inc.

       135,410

  

       674,048

 

 

 

 Services-General Medical & Surgical Hospitals - 0.11%

 

   1,000

Tenet Healthcare Corporation *

         10,980

   

 Services-Prepackaged Software - 4.05%

 

  11,900

Microsoft Corporation

       317,968

   3,000

Oracle Corporation*

         41,160

   1,500

Symantec Corporation*

         38,640

 

 

       397,768

   

 Sporting & Athletic Goods - 0.14%

 

   1,000

Callaway Golf Company

         13,500

 

 

 

 State Commercial Banks - 0.84%

 

      500

Fifth Third Bancorp

         23,650

   1,500

 J.P. Morgan & Company, Inc.

         58,515

 

 

         82,165

   

 Telephone Communications (No Radiotelephone) - 0.52%

 

   2,000

SBC Communications, Inc.

         51,540

 

 

 

 Transportation Services - 0.56%

 

   2,000

Interactive Corporation. *

         55,240

   

Wholesale-Drugs, Proprietaries & Druggists' Sundries - 0.30%

 

      500

Amerisourcebergen Corporation

         29,340

 

 

 

   

 Total for Common Stock -51.86% (Cost 5,566,872)

    5,096,679

   

 Cash - Equivalents -  41.71%

 

4,099,590

First American Treasury Obligation Class A 1.11% **

     4,099,590

 

(Cost 4,099,590)

 

   

 

Total Investments   93.57%

     9,196,269

 

 (Cost  $9,666,462)

 

 

 

 

 

Other Assets Less Liabilities - 6.43%

       631,741

 

 

 

 

Net Assets   100.00%

     9,828,010

 

 

 

*  Non-income producing securities.

 

** Variable Rate Security at  December 31, 2004

 
   

NOTES TO FINANCIAL STATEMENTS

 

The Jhaveri Value Fund

 
   
 

1. SECURITY TRANSACTIONS

 
   

At December 31, 2004, the net unrealized depreciation on investments, based on cost for federal

 income tax purposes of $5,566,872 amounted to $470,192 which consisted of aggregate gross

 unrealized appreciation of  $112,959 and aggregate gross unrealized depreciation of $583,151.


ITEM 2. CONTROLS AND PROCEDURES.


(a)

EVALUATION OF DISCLOSURE CONTROLS AND PROCEDURES. The Registrant maintains disclosure controls and procedures that are designed to ensure that information required to be disclosed in the Registrant's filings under the Securities Exchange Act of 1934 and the Investment Company Act of 1940 is recorded, processed, summarized and reported within the periods specified in the rules and forms of the Securities and Exchange Commission. Such information is accumulated and communicated to the Registrant's management, including its principal executive officer and principal financial officer, as appropriate, to allow timely decisions regarding required disclosure. The Registrant's management, including the principal executive officer and the principal financial officer, recognizes that any set of controls and procedures, no matter how well designed and operated, can provide only r easonable assurance of achieving the desired control objectives.

Within 90 days prior to the filing date of this Quarterly Schedule of Portfolio Holdings on Form N-Q, the Registrant had carried out an evaluation, under the supervision and with the participation of the Registrant's management, including the Registrant's principal executive officer and the Registrant's principal financial officer, of the effectiveness of the design and operation of the Registrant's disclosure controls and procedures. Based on such evaluation, the Registrant's principal executive officer and principal financial officer concluded that the Registrant's disclosure controls and procedures are effective.

(b)

CHANGES IN INTERNAL CONTROLS. There have been no significant changes in the Registrant's internal controls or in other factors that could significantly affect the internal controls subsequent to the date of their evaluation in connection with the preparation of this Quarterly Schedule of Portfolio Holdings on Form N-Q.


ITEM 3. EXHIBITS.


Certifications pursuant to Rule 30a-2(a) under the 1940 Act and Section 302 of the Sarbanes-Oxley Act of 2002 are attached hereto.


SIGNATURES


Pursuant to the requirements of the Securities Exchange Act of 1934 and the Investment Company Act of 1940, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.


The Jhaveri Trust


By /s/Ramesh C. Jhaveri

*Ramesh C. Jhaveri

 Chief Executive Officer


Date February 25, 2005



Pursuant to the requirements of the Securities Exchange Act of 1934 and the Investment Company Act of 1940, this report has been signed below by the following persons on behalf of the registrant and in the capacities and on the dates indicated.


By /s/Ramesh C. Jhaveri

*Ramesh C. Jhaveri

 Chief Executive Officer


Date February 25, 2005


By /s/Saumil R. Jhaveri

*Saumil R. Jhaveri

 Chief Financial Officer


Date February 25, 2005


* Print the name and title of each signing officer under his or her signature.


EX-99.CERT 2 jhaverinqcert.htm Exhibit 99

Exhibit 99.CERT

CERTIFICATIONS


I, Ramesh C. Jhaveri, certify that:


1.

I have reviewed this report on Form N-Q of The Jhaveri Trust;

2.

Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3.

Based on my knowledge, the schedules of investments included in this report fairly present in all material respects the investments of the registrant as of the end of the fiscal quarter for which the report is filed;

4.

The registrant's other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Rule 30a-3(c) under the Investment Company Act of 1940) for the registrant and have:

a)

Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

b)

[Omitted]

c)

Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of a date within 90 days prior to the filing date of this report based on such evaluation; and

d)

Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal half-year (the registrant’s second fiscal half-year in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5.

The registrant's other certifying officer(s) and I have disclosed to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):

a)

All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize, and report financial information; and

b)

Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.



Date: February 25, 2005

/s/Ramesh C. Jhaveri

Ramesh C. Jhaveri, Chief Executive Officer



CERTIFICATIONS


I, Saumil R. Jhaveri, certify that:


6.

I have reviewed this report on Form N-Q of The Jhaveri Trust;

7.

Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

8.

Based on my knowledge, the schedules of investments included in this report fairly present in all material respects the investments of the registrant as of the end of the fiscal quarter for which the report is filed;

9.

The registrant's other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Rule 30a-3(c) under the Investment Company Act of 1940) for the registrant and have:

a)

Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

b)

[Omitted]

c)

Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of a date within 90 days prior to the filing date of this report based on such evaluation; and

d)

Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal half-year (the registrant’s second fiscal half-year in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

10.

The registrant's other certifying officer(s) and I have disclosed to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):

a)

All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize, and report financial information; and

b)

Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.



Date: February 25, 2005

/s/Saumil R. Jhaveri

Saumil R. Jhaveri, Chief Financial Officer


-----END PRIVACY-ENHANCED MESSAGE-----